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Supplement  
Figure notes  and Table titles 
 
Figure S1: Bubble plot of the relationship between the polygenicity prior and the effect size in the 
polygenic risk score analyses. Note the increase in effect size with the increase in polygenicity prior. 
The solid line indicates the best fit obtained from the meta-regression model (model 3). The dashed 
lines reflect the upper and lower confidence bounds.  
Figure S2 Bubble plot of the approximated genetic correlations between schizophrenia and 
childhood psychopathology per disorder given the assumptions described in Supplementary Note 1. 
In this figure, we assume the variance explained by all markers in childhood psychopathology is 
constant and 20%. Circles indicate the transformed observed regression coefficients to genetic 
correlations (ALSPAC in red, NTR in blue). The size of the circles is proportional to the inverse of the 
variance, and thus larger circles reflect more accurate estimates. The solid line reflects the genetic 
correlation and the dashed lines indicate the upper and lower 95% confidence interval around the 
genetic correlation, quantifying the uncertainty in the meta-regression but not in the variance in 
childhood psychopathology explained by all measured markers, or the estimate of the number of 
independent markers.  
Figure S3 Bubble plot of the approximated genetic correlations between schizophrenia and 
childhood psychopathology per disorder given the assumptions described in Supplementary Note 1. 
In this figure, we assume the variance explained by all markers in childhood psychopathology is 
constant and 10%. Circles indicate the transformed observed regression coefficients to genetic 
correlations (ALSPAC in red, NTR in blue). The size of the circles is proportional to the inverse of the 
variance, and thus larger circles reflect more accurate estimates. The solid line reflects the genetic 
correlation and the dashed lines indicate the upper and lower 95% confidence interval around the 
genetic correlation, quantifying the uncertainty in the meta-regression but not in the variance in 
childhood psychopathology explained by all measured markers, or the estimate of the number of 





Table S1: Sample sizes per age group for the NTR, ALSPAC and combined 
 
Table S2: Descriptives  
 
Table S3: Prediction of non-participation based on the schizophrenia PRS 
 
Table S4: Prediction of non-participation based on psychopathology scores at an earlier time point 
Supplementary Note 1 
This note accompanies the manuscript entitled: “Genetic overlap between schizophrenia and 
developmental psychopathology: a longitudinal analysis of common childhood disorders between 
age 7 and 15”. All data described here and analyses presented here serve to support the conclusions 
of the manuscript as published.  
Phenotype descriptives 
Table S2 presents the mean scores on the DSM-IV based scales of anxiety, depression, ADHD, 
ODD/CD for males and females in the NTR at different ages (left) as well as the percentages of male 
and female ALSPAC participants with these diagnoses, defined as a score of 4 or 5 on the DAWBA 
(right). (Note that in the analyses, the 6-category DAWBA band was used as outcome variable since 
this is a more informative measure than the dichotomous DAWBA diagnosis). 
Genotyping and genotype quality control: 
The NTR participants were genotyped on Affymetrix 6.0, Affymetrix-perlegen 5.0, Illumina 660 and 
Omni express (1M) platforms. Array specific calls and cleaning were performed before data from 
different platforms were combined. Data from different platforms were strand aligned, SNPs with a 
minor allele frequency below 1%, a HWE p-value < 1*10-5 and with a genotype missingness rate > 
10% or call rate < 95% were removed. Individuals with an excessive or low heterozygosity were 
removed (F > .10 or F < .10). After QC, genotypes were imputed to a common set of SNPs based on 
the goNL reference set.1 SNPs were imputed that were not directly measured on each platform. 
Samples were excluded when reported gender did not match biological gender or when individuals 
were of non-European ancestry based on principle component analysis.2 In the NTR, sex, call rate, F 
(inbreeding coefficient), five principle components based on global ancestry  and five principal 
components correcting for local ancestry differences within the Netherlands were included as 
covariates in all analyses .2  
In ALSPAC, children were genotyped on the Illumina HumanHap550 quad chip genotyping platforms. 
The raw genome-wide data were subjected to standard quality control methods. Individuals were 
excluded on the basis of gender mismatches, minimal or excessive heterozygosity, disproportionate 
levels of individual missingness (>3%), and insufficient sample replication (IBD < 0.8). Population 
stratification was assessed by multidimensional scaling analysis, and compared with Hapmap II 
(release 22); all individuals of non-European ancestry were removed. SNPs with a minor allele 
frequency of < 1%, a call rate of < 95%, or evidence for violations of Hardy-Weinberg equilibrium (p < 
5E-7) were removed. Cryptic relatedness was measured as proportion of identity by descent (IBD > 
0.1). Related subjects that passed all other quality control thresholds were retained during 
subsequent phasing and imputation, though not association. Imputation of the target data was 
performed using Impute V2.2.23 against the 1000 genomes phase 1 version 3 reference panel, using 
all 2186 reference haplotypes (including non-Europeans).4 As the ALSPAC sample, after QC, is 
assumed to be genetically homogeneous with respect to ancestry and local ancestry differences, no 
principal components were added as covariates, sex was included as covariate in all analyses.  
The correction for the presence of overlapping subjects at the different ages of measurement, and 
the correlation between the polygenic predictors. 
In the meta-regression analysis performed we had a set of 6 predictors X, and 32 outcomes Y. We 






We constructed an approximate error correlation matrix (i.e. the correlation between the regression 
parameters B) for a series of univariate regressions of p equal to:  
 
We specified the error covariance matrix as: . Where se was a 192 x 192 diagonal 
matrix with the standard associated with each of the parameters B on the diagonal. The errors were 
assumed to be independent between cohorts and therefore correlations between cohorts were set 
to zero in matrix .  Based on the specified error correlation matrix, we performed the meta-
analysis and meta-regression of the beta’s obtained from the univariate regression analyses. To test 
whether the proposed error correlation matrix accurately accounted for the dependence induced by 
correlated predictors and outcomes, we performed  type 1 error simulations. 
We simulated 3 traits (Y) (correlations between .3 and .5) and 3 polygenic scores (X) (correlations 
between .9 and .8) for 100 subjects. In each simulation there was no true association between PRS 
and traits. We regressed each trait Y on each polygenic score X, and meta-analyzed the 9 test 
statistics obtained from these regressions, correcting for the dependence between traits and risk 
scores as outlined above. Given a small sample in the univariate regressions (N=100) the following 
slightly liberal type 1 error rates were observed. The liberal type-1 error was likely induced by the 
fact that the test statistic obtained in each meta-analysis followed a t-distribution and not a normal 
distribution. 
 





Simulating data given a larger sample of 1000 subjects in the initial univariate regressions the 
following, accurate, type 1 error rates were observed:  





In our study, the sample size for the individual univariate regressions to be meta-analyzed ranged 
between 1200 and 6000 thus we were satisfied with the results of the type-1 error simulations.  
A different limitation was that the error covariance as specified here assumed total sample overlap, 
and the absence of any covariates. However, we did include covariates to control for population 
stratification and mean differences between male and female participants. These effects were 
assumed to be sufficiently small to allow our approximation to be valid. Strong covariate effects and 
substantial dropout would likely reduce power to detect an overall or age effect, and possibly 
increase type 1 error in some situations. As a form of sensitivity analysis the off diagonal elements of 
the phenotypic correlation matrices in ALSPAC and NTR were shrunk by 50% or 33% and increased by 
up to 10% to simulate the effect of less than total sample overlap or the effect of covariates changing 
the error covariance matrix. The conclusions remained virtually unchanged. Model 3 as described in 
the main text, had the best model fit when the off-diagonal elements in the phenotypic covariance 
matrix were reduced 50% or 33% and model 4 performed best when the phenotypic covariance was 
increased 10%. Parameter estimates and test statistics in model 3,  fitted on the increased or 
decreased error covariance matrix were virtually unchanged. To conclude, the sensitivity analyses 




Parametric resampling of the data to account for the influence of sampling fluctuation 
To quantify the influence of sampling fluctuation on our model selection, we resampled the input for 
the meta-regression from a multivariate normal distribution with means equal to the observed 
regression coefficients in the univariate PRS analyses, and covariance equal to the above specified 
error covariance matrix. Unlike non-parametric bootstrapping this technique makes assumptions 
about the asymptotic distributions of test statistics. However parametric resampling does allow for 
quantification of sampling variance in the model selection procedure. 
We resampled 1000 datasets, on each of these the model selection procedure was repeated, the 
percentages in Table 1 (main text) reflect the percentage of resample datasets for which each model 
best fitted the data. The results represent the expected sample fluctuation in the model selection 
procedure induced by sample fluctuation, assuming the estimated effect sizes and error covariance 
are representative of the true effects and error covariance.  
Mixed effects meta-regression to account for residual heterogeneity 
In some cases a random effect which is unjustly omitted from the model can induce false positive 
results in meta-regression. Given only two cohorts are in the current study, a full mixed meta-
regression makes little sense. However as a robustness check we fit two meta-regression models 
which allow for random effects and determine their influence on the results.  
The best fitting fixed effects meta-analysis model (model 3; Table 1) revealed a moderate amount of 
residual variation not accounted for by the meta-regression model (Qe = 226,49, df=181, p = 0.0122).  
We therefore performed two additional  random effects meta-analyses. Our first random effect 
model allowed for (correlated) random effects for each observed effect size, where the correlations 
between the random effects were assumed to be equal to the error covariance. The first mixed 
effects model significantly improved the model fit (LRT=8.81, df = 1, p = 0.0009). The fixed effects 
age, ODD/CD, and agexADHD were all significant (p < 0.05) in this mixed effects model (as they were 
in the fixed effects meta-regression model), but the effect agexODD/CD no longer reached 
significance (p = 0.0681) . The omnibus test including all meta-regression parameters also remained 
significant (QM = 37.0610, df = 10, p < 0.0001). The second mixed effects model included a random 
intercept, i.e., in this model, the only dependence between effect sizes was introduced by the meta-
regressors or the error covariance. This second random effects model also significantly improved 
model fit over the fixed effects model (LRT = 14.7982, df=1, p < 0.0001). The second mixed effects 
model revealed a significant age effect and agexADHD effect (p < 0.05), but no significant ODD/CD 
and agexODD/CD effects. The overall test of parameters remained significant (QM= 30.0032, df=10, p 
= 0.0009). To conclude, both random effects models retained the main conclusions as the fixed 
effects model, i.e., an increasing association between schizophrenia PRS and childhood 
psychopathology with age, and some differences between the disorders in their relationship with 
schizophrenia.  
 
Estimating genetic correlations based on the results from the polygenic risk score analyses 
 The univariate polygenic risk analyses results were obtained from either an ordered  logistic 
regression (ALSPAC) or  general estimation equations (GEE in NTR).  For explanatory purpose we 
consider an OLS  regression: 
 
where the trait (y) and the PRS are scaled to unit variance and centered. The regression contained a 
number of other covariates (such as sex and principal components). Assuming the effects of the 
principal components and sex on the phenotypes were small to negligible, the square of B1 (B12) is 
equal to the variance explained in the phenotype by the PRS. We further assume that the squared 
predicted outcome of the multivariate meta-analyses correspond to R2. Given these assumptions we 
used the previously derived relationship between R2 and genetic correlation5 to approximate the 
genetic correlations between childhood psychopathology and schizophrenia: 
 
 
The inverse relationship equals: 
 
From which we can obtain:  
 
 
where N equals sample size in the discovery sample, M equals the independent number of genetic 
effects in the set of SNPs,  is the genetic covariance between target and discovery trait and 
 equals the genetic variance explained by all measured markers in the target trait. As the 
discovery sample here was an ascertained case control sample (34241 cases and 45604 controls), we 
substituted the effective N using the effective sample size formula proposed by Wilier et al.6 
 
 
Note that N is approximate  and R2 is estimated directly in the PRS analyses. Therefore, we needed to 
assume values for M and . Any uncertainty in these values  will not be reflected in the 
confidence bounds around the genetic covariance.  We assumed M to equal 200.000. To explore the 
influence of the uncertainty in  on the estimate of rg we computed the genetic correlations 
assuming the heritability explained by all SNPs included in the score for childhood psychopathology 
to be 0.15 (Figure 3), 0.20 (Figure S1) or 0.10 ( Figure S2). Note that we did not account for 
differences in the variance explained by the SNPs for the different psychopathologies at the different 
ages. We further assumed that the equations remained valid for estimates of B obtained from GEE 
(to correct for the presence of related samples) or ordered logistic regression (to correct for the fact 
that the ALSPAC phenotype was an ordered categorical variable). 
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